BioScrip Investor Wants More Details On Option Care Merger
By Rose Krebs ( June 10, 2019, 6:38 PM EDT) -- An investor hit home infusion care provider BioScrip Inc. with a proposed class action Friday in Delaware Chancery Court saying that company directors have not provided enough details about a merger that would issue more than 500 million new shares of company stock while diluting current investors down to a 20% holding....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.